Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96-Reference-Cited by-同舟云学术

Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96

Published:2023-07 Issue: Volume:36 Page:100769
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Su Bin,Gao Guiju,Wang Min,Lu Yanqiu,Li Linghua,Chen Chen,Chen Yuanyuan,Song Chuan,Yu Fengting,Li Ying,Liu Yixin,Luo Yang,He Haolan,Cheng Cong,Xu Lixia,Zhang Tong,Sun Lijun,Liu An,Xia Wei,Qin Yuanyuan,Zhao Qingxia,Wei Hongxia,Cai Weiping,Chen Yaokai,Zhang Fujie^ORCID,Wu Hao

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference31 articles.

1. Update of recommendations on first- and second-line antiretroviral regimens;WHO,2019

2. Dolutegravir plus two different prodrugs of tenofovir to treat HIV;Venter;N Engl J Med,2019

3. Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy;Lu;AIDS,2022

4. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021);Chin J AIDS STD,2021

5. Efavirenz--still first-line king?;Best;Expet Opin Drug Metabol Toxicol,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative study based on ainuovirine/lamivudine/tenofovir against HIV-1;International Journal of STD & AIDS;2024-09-13

2. Comparative Studies on the Efficacy and Safety of Ainuovirine-Based Versus Efavirenz-Based Antiretroviral Therapy in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China;AIDS Research and Human Retroviruses;2024-08-01

3. Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial;The Lancet Regional Health - Western Pacific;2024-08

4. Efficacy and effect on lipid profiles of Ainuovirine-based regimen versus Efavirenz-based regimen in treatment-naïve people with HIV-1 at week 24: A real-world, retrospective, multi-center cohort study;BioScience Trends;2024-04-30

5. Efficacy and effect on lipid profiles of switching to ainuovirine-based regimen versus continuing efavirenz-based regimen in people with HIV-1: 24-week results from a real-world, retrospective, multi-center cohort study;Antimicrobial Agents and Chemotherapy;2024-04-03